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Stem cells derived from a variety of tissues havea potential capability to differentiate into neuralcells. Some studies, however, find that almost
all the stem cell lines tend to differentiate into glial cells
rather than neurons.1 It is well known that glial cell prolif-
eration is the basis of nerve tissue reparation in the late
period of brain injuries, but at the same time it restricts
the motor function recuperation based on neuronal
structure. In recent years, it is reported that brain-de-
rived neurotrophic factor (BDNF) can increase the differ-
entiation ratio of stem cells into neurons.2 This study
aims to explore the ability of BDNF gene-modified stem
cells to further restore post-traumatic motor function.
METHODS
Material and reagents
Fetal bovine serum (FBS, Hangzhou, China), trypsin
(Gibson,USA), pAdeno-BDNF adenovirus (Zhongshan
University, China), FITC tag streaming antibody CD29,
CD31, CD44, CD45 and CD105 (Erotic,UK), rabbit anti-
human CD34 antibody (Santa Cruz, USA.), goat anti-
mouse glial f ibrillary acidic protein (GFAP) and
rhodamine fluorescent antibody (Beijing, China), rabbit
anti-mouse neuron specific enolase (NSE) antibody and
goat anti-mouse BDNF antibody (Boshide,Wuhan,
China) were used in this study. A total of 36 male thy-
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Objective:    To promote stem cells differentiation into
neurons and enhance neuromotor function after brain in-
jury through brain-derived neurotrophic factor (BDNF)
induction.
 Methods:    Recombinant adenovirus vector was ap-
plied to the transfection of BDNF into human-derived um-
bilical cord mesenchymal stem cells (UCMSCs). Enzyme
linked immunosorbent assay (ELISA) was used to deter-
mine the secretion phase of BDNF. The brain injury model
of athymic mice induced by hydraulic pressure percussion
was established for transplantation of stem cells into the
edge of injury site. Nerve function scores were obtained,
and the expression level of transfected and non-transfected
BDNF, proportion of neuron specific enolase (NSE) and
glial fibrillary acidic protein (GFAP), and the number of
apoptosis cells were compared respectively.
Results:    The BDNF expression achieved its stabiliza-
tion at a high level 72 hours after gene transfection. The
mouse obtained a better score of nerve function, and the
proportion of the NSE-positive cells increased significantly
(P<0.05), but GFAP-positive cells decreased in BDNF-
UCMSCs group compared with the other two groups (P<0.05).
At the site of high expression of BDNF, the number of
apoptosis cells decreased markedly.
Conclusion:    BDNF gene can promote the differentia-
tion of the stem cells into neurons rather than glial cells, and
enhance neuromotor function after brain injury.
Key words:    Brain-derived neurotrophic factor; Stem
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mus-free mice, weighing 50 g each, purchased from
the Chinese Academy of Military Medical Sciences,
were raised in the animal laboratory of Tianjin Medical
University.
Culture and identification of UCMSCs
Umbilical cord was immersed into serum-free DMEM
under aseptic condition, and the residual blood was
washed off with PBS. Then cut the umbilical cord tis-
sue into 1 mm3 sections, which were thereafter digested
by collagenase IV and 0.1% trypsin, filtered with cell
sieve, and then centrifuged. We inoculated the cell
suspension into 10 cm plastic dishes with the density
of 1.0 ×106 each, and cultivated them under the condi-
tion of 37°C, 5% CO2 and saturated humidity in cell
incubator. About 10-14 days later, when single-adher-
ent cells grew into 90% fusion, use 0.25% trypsin for
digestion, with 1:2 passage. Select the 4th passage
cells (1×106) into PBS to suspension, respectively add
CD29, CD31, CD44, CD45 and CD105 antibody that
marked with their matching fluorescein isothiocyanate
(FITC) and stained in darkness about 30 minutes. The
CD34 was detected by indirect fluorescent label and
tested by the flow cytometer.
BDNF gene transfection and secretion phase de-
tection
Well-grown UCMSCs were selected and inoculated
into 24-well culture dishes. When the cellular density
grew into 60% to 70% confluent, we proceeded recom-
binant adenovirus transfection of BDNF gene. At the
time points of 24 h, 48 h, 72 h, 96 h, 120 h after
transfection, the expression level of BDNF was detected
by ELISA, and the non-transfected UCMSCs served as
control. The procedures of ELISA were carried out ac-
cording to specification.3
Establishment of brain injury model
The thymus-free mice were anesthetized by intrap-
eritoneal injection of 10% chloral hydrate and fixed on
a stereotaxic apparatus and exposed the skull under
sterile conditions. At the point of 2.0 mm rearward from
the anterior fontanelle and 2.0 mm right to the midline,
open a 4 mm diameter bone window and maintain the
integrity of the dura mater. Then fix a percussion-tube
on the edge of bone window, connect it to the hydraulic
craniocerebral trauma instrument, keep the tube closed,
and implement an impact injury at a peak impacting
stress of 0.20 MPa and mean time of 20 ms.
Experimental group and UCMSCs transplantation
All the animals were divided into three groups, i.e.
control group (n=12, without stem cell transplantation),
simple UCMSCs transplantation group (n=12, simple
UCMSCs transplantation) and BDNF-UCMSCs trans-
plantation group (n=12,  UCMSCs transplantation modi-
fied by BDNF gene). The well-grown UCMSCs of trans-
fected and non-transfected BDNF genes were selected
to accept conventional trypsin digestion and sufficient
suspension, so as to make single cell suspension ready
for use. Twenty-four hours after injury, at a speed of
1×106 /10 µl, UCMSCs were evenly injected via the edge
of bone window into the traumatic brain cortex.
Measurement of parameters
(1) Neural function scores: Neural function score
was carried out in 8 mice in each group on the 7th day,
14th day, 21th day and 28th day before treatment. The
scoring method we used was from the literarure.4 (2)
The expression BDNF, NSE and GFAP at the edge of
the traumatic site: Four mice in each group were ex-
ecuted on the 7th day, and their brain tissues were
made into paraffin sections which afterwards were de-
tected by immunofluorescence test. The dilution ratios
of BDNF antibody, GFAP and NSE were 1:1000, 1:500,
and 1:1000, respectively. (3) Detection of apoptosis in
situ was conducted according to instructions of in situ
apoptosis detection kit.
Statistical analysis
SPSS 13.0 statistical software was used for data
analysis. The comparison between two groups was
made by Student’s t test, and multi-group comparisons
by ANOVA test. P<0.05 was considered to be statisti-
cally significant.
RESULTS
Identification of UCMSCs
The results of the surface markers identified by flow
cytometry were: CD29 (97.69%), CD44 (98.17%),
CD105 (98.38%) were positively expressed, and CD31
(2.67%), CD34 (3.09%), CD45 (3.38%) negatively
expressed. Among them, CD29, CD44, CD105 were
the specific markers of UCMSCs expression.  CD31
was the marker of endothelial cells, CD34 and CD45
were hematopoietic stem cell markers. Multi-indicator
detection confirmed that UCMSCs with a high purity of
variety could meet the experimental requirements (Fig. 1).
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BDNF secretion phase
The constantly low expression of BDNF was de-
tected in the UCMSCs medium of  non-transfected
BDNF gene (Fig.2), but continuously increased expres-
sion of BDNF was seen in the UCMSCs medium of trans-
fected BDNF, and maintained a relatively high level 72
hours later.
motor function than the simple UCMSCs transplant
group (P<0.05).
Expression of BDNF, GFAP and NSE at the wound
edge and apoptosis detection in situ
The selected regions were just on the edge of brain
traumatic site, i.e. the site of stem cell transplantation
(Fig.3). The green fluorescence in the cytoplasm sug-
gested FITC-positive cells, while red ones suggested
TRATIC-positive cells. The expression of BDNF was low
both in the control group and simple UCMSCs trans-
plant group. There was no significant difference between
them (P>0.05). A large number of BDNF-positive cells
can be seen at the edge of traumatic focus in BDNF-
UCMSCs transplant group. Compared with the control
group and simple UCMSCs transplant group, there were
significant statistical differences (P<0.01). Compared with
the control group, the number of NSE and GFAP-positive
cells increased significantly in UCMSCs transplant group,
but the proportion of GFAP-positive cells (91.3%±7.8%)
was much more than that of NSE-positive cells (8.7%±
3.1%). At the same time, the proportion of GFAP-posi-
tive cells (57.3%±8.9%) decreased significantly in BDNF-
UCMSCs transplant group, while the proportion of NSE-
positive cells (41.7%±7.4%) increased. It indicated that
UCMSCs modified by BDNF gene had strong differen-
tiation potential into neurons rather than into glial cells.
Cell apoptosis in situ appeared near the traumatic focus.
It can be seen that the number of apoptosis cells under
microscopic vision in UCMSCs transplant group (84.5±21.3)
was less than that in the control group (191.5±27.1).
The BDNF-UCMSCs transplant group had a smaller num-
ber of apoptotic cells than the other two groups, and few
apoptotic cells (21.5±7.3) were seen locally. There was
significant difference when compared with simple
UCMSCs transplant group (P<0.01).
Neural function scores
At all the 5 time points, the neural function of
UCMSCs transplant group  was better than that with-
out stem cell transplantation (Table 1). Meanwhile, the
BDNF-UCMSCs transplant group had better neural
Table 1. Comparison of neurologic impairment scores in different groups
t 1: compared with the control group, t 2: compared with the UCMSCs group.
 Groups                  n             Before treatment                 7d                        14d                       21d                     28d
14.19 ± 1.78
11.37 ± 2.111
  7.36 ± 1.042
      2.889
    <0.05
      3.312
    <0.05
Control
UCMSCs
BDNFUCMSCs
t 1
P 1
t 2
P 2
8
8
8
37.85 ± 4.29
36.98 ± 3.72
37.91 ± 2.02
      0.433
    >0.05
      0.036
    >0.05
24.12 ± 3.29
19.74 ± 2.731
15.23 ± 3.062
       2.898
     <0.05
       5.598
     <0.05
19.01 ± 4.41
16.35 ± 2.441
12.31 ± 2.732
       1.493
     <0.05
       3.653
     <0.05
15.03 ± 3.31
14.15 ± 2.311
  9.11 ± 1.372
       0.617
     <0.05
       4.676
     <0.05
Fig.1. The surface antigens expression of UCMSCs identified
by flow cytometry analysis (positive: CD29=99.61%,CD44=99.
10%,CD105=99.17%; negative: CD31=2.17%,CD34=3.45%,
CD45=4.79%).
Fig.2. Comparison of the BDNF expression level in cellular condi-
tioned medium at different time points.
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DISCUSSION
There are two major pathophysiological events for
traumatic brain injury patients, i.e. nerve tissue resto-
ration and motor function recovery. The structural ba-
sis of nerve tissue reparation is glial proliferation and
regeneration, while motor function commutation is based
on the functional compensation of undamaged neurons
and the differentiation into neurons from neural stem
cells that are stored sub-ependymal and  the back side
of the hippocampus region.5 For the majority of adults
and adolescents, the function compensation is very
limited, which is also an important reason why brain
injury patients cannot effectively restore to normal mo-
tor function after long-term motor dysfunction. In addition,
the proliferation of a large number of glial cells have
also become a potential factor for seizures.6
In recent years, stem cell transplantation makes it
possible to fundamentally improve motor function of brain
trauma patients. However, many studies have confirmed
that most of the transplanted stem cells, under the in-
duction of brain micro-environment, differentiate into glial
cells rather than neurons, which to some extent limits
the application of stem cells transplantation.7 As a result,
whether  can we solve this problem will lead a profound
impact on stem cell transplantation. Studies have shown
that BDNF can promote stem cell differentiation into
neurons to certain degrees.8 In light of previous re-
searches on UCMSCs,9, 10 our study used adenovirus
vector to transfect BDNF into UCMSCs, observed the
differentiation results of BDNF-UCMSCs into neurons
or glial cells in vivo, and tested the nerve function res-
toration in rats subjected to brain injury.
The reasons why we transplanted stem cells to the
edge of traumatic focus are mainly considered two
points: (1) There are a large amount of toxic substance
accumulation in traumatic brain area because of se-
vere hypoxia and ischemia, which is not conducive to
the survival, growth and differentiation of local stem cells.
(2) There are a few normal nerve cells near the trau-
matic sites, to whom timely nutrition and effective treat-
ment are essential to the nerve function recovery after
Fig.3. The detection of expression of BDNF, GFAP and NSE, and cell apoptosis in situ (bar=50 µm).
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traumatic brain injury.
 In addition, in order to reduce post-transplant im-
munologic rejection when injecting human-derived
UCMSCs into animals brain tissue, we chose thymus-
free mice as transplantation objects. By establishing a
good brain injury model, as well as a stable environ-
ment for stem cell transplantation, we detected the gene
expression of BDNF, NSE (characteristic protein marker
for neurons), and GFAP (characteristic protein marker
for glial cells) near the brain trauma sites. It was found
that there were a large number of GFAP-positive cells,
but very few NSE-positive cells in the UCMSCs trans-
plant group, suggesting that these grafted UCMSCs,
under the influence of brain microenvironment, tend to
differentiate into glial cells rather than neurons. This
result is consistent with other previous reports.
Meanwhile, in BDNF-UCMSCs transplant group we
found high expression of BDNF and numerous GFAP-
positive cells and some NSE-positive cells at the edge
of the traumatic brain area. Compared with simple
UCMSCs transplant group, the proportion of GFAP-posi-
tive cells were significantly reduced (from 91.3%±7.8%
down to 57.3%± 8.9%), while the proportion of NSE-
positive cells increased (from 8.7%± 3.1% up to 41.7%
±7.4%). These results indicate that the effective trans-
fection and expression of BDNF gene can promote the
proportion of UCMSCs differentiation into neurons and
at the same time retard the differentiation into glial cells.
In addition, we observed that apoptosis cells were
greatly diminished at the site of the high expression of
BDNF, and motor function scores were superior to that
of low expression of BDNF groups (control group and
simple UCMSCs transplant groups). In general, BDNF,
by promoting the proportion of stem cells differentiation
into neurons, plus its role in nerve nutrition, can im-
prove the motor function of experimental animals after
traumatic brain injury.
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